Data suggests that 1.2 million deaths in India are due to antimicrobial resistance (AMR), with an estimated 10 million deaths by 2050
Read More
The investment, in exchange for an undisclosed equity stake, is set to expedite Orbicular's product pipeline development
Read More
On an yearly basis, gross profit for FY24 was Rs16,291 million, up 22 per cent from Rs 13,328 million in FY23
Read More
Technology, skills and learnings are industry-agnostic. It's your mindset that enables the implementation of a basic idea from one industry into something revolutionary in another says Priyanka
Read More
Established in 2011 as a 50:50 joint venture for pharmaceutical sales and marketing in India, Bayer has now acquired the remaining 25 per cent stake to secure full ownership of the entity, in accordance with pre-agreed joint venture terms
Read More
The ‘Cure and Beyond’ campaign not only aims to spotlight innovation as the cornerstone of Emcure's operations but also endeavors to instill a sense of thought leadership within the Indian pharmaceutical sector
Read More
